当前位置: X-MOL 学术Public Health Genom. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Factors Influencing Discussion of Cancer Genetic Testing with Health-Care Providers in a Population-Based Survey
Public Health Genomics ( IF 1.7 ) Pub Date : 2021-04-22 , DOI: 10.1159/000515465
Sukh Makhnoon 1 , Robert Yu 2 , Sonia A Cunningham 3 , Susan K Peterson 1 , Sanjay Shete 2, 3, 4
Affiliation  

Introduction: Discussion of cancer genetic testing with health-care providers (HCPs) is necessary to undergo testing to inform cancer risk assessment and prevention. Given the rapid evolution in genetic testing practice in oncology, we describe the current landscape of population-level cancer genetic testing behaviors. Methods: A questionnaire including items regarding discussion of cancer genetic testing with HCPs was administered to a nonprobability sample (N = 2,029) of the Texas population. Results: Overall, 11% of respondents discussed cancer genetic testing with HCPs. In multivariable analysis, discussion was significantly related to having a personal history of breast/ovarian/colon cancer (OR = 11.57, 95% CI = 5.34–25.03), personal history of other cancer (OR = 3.18, 95% CI = 1.69–5.97), and health information-seeking behaviors (OR = 1.73, 95% CI = 1.12–2.66). Surprisingly, respondents who believed that inherited predispositions in addition to other modifiable risk factors cause cancer were less likely to discuss genetic testing compared to those who did not believe that inherited cancer predispositions cause cancer (OR = 0.54, 95% CI = 0.36–0.79). Discussion: The high discussion rate may be attributed to increased public awareness of genetic testing and adoption of more inclusive clinical genetic testing guidelines. The findings suggest that efforts to increase public awareness of the utility of genetic testing on personalized cancer risk assessment and cancer prevention are needed.
Public Health Genomics


中文翻译:

在基于人群的调查中影响与医疗保健提供者讨论癌症基因检测的因素

简介:有必要与医疗保健提供者 (HCP) 讨论癌症基因检测,以便进行检测以告知癌症风险评估和预防。鉴于肿瘤学中基因检测实践的快速发展,我们描述了当前人群水平的癌症基因检测行为。方法:对德克萨斯州人口的非概率样本 ( N = 2,029) 进行问卷调查,其中包括有关 HCP 癌症基因检测讨论的项目结果:总体而言,11% 的受访者与 HCP 讨论了癌症基因检测。在多变量分析中,讨论与乳腺癌/卵巢癌/结肠癌的个人病史(OR = 11.57, 95% CI = 5.34-25.03)、其他癌症的个人病史(OR = 3.18, 95% CI = 1.69- 5.97)和健康信息寻求行为(OR = 1.73, 95% CI = 1.12–2.66)。令人惊讶的是,与不认为遗传性癌症易感性导致癌症的人相比,认为遗传性易感性以及其他可改变的风险因素导致癌症的受访者不太可能讨论基因检测(OR = 0.54, 95% CI = 0.36-0.79) . 讨论:高讨论率可能归因于公众对基因检测的认识提高和采用更具包容性的临床基因检测指南。研究结果表明,需要努力提高公众对基因检测在个性化癌症风险评估和癌症预防中的效用的认识。
公共卫生基因组学
更新日期:2021-04-22
down
wechat
bug